2014 Report on the International (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal Drugs) Ophthalmic Drugs Market - Forecast to 2018
DUBLIN, June 27, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/9kp9sq/ophthalmic_drugs) has announced the addition of the "2014 Report on the International (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal Drugs) Ophthalmic Drugs Market - Forecast to 2018" report to their offering.
The global ophthalmic drugs market is rapidly growing due to increasing prevalence of eye disorders such as glaucoma, dry eye diseases and retinal diseases. Changing lifestyle, improved medical infrastructure, technological changes, increase in healthcare spending and aging population is also supporting the growth of the ophthalmic drugs market.
Glaucoma is the largest drugs segment in global ophthalmic drugs market. Some of the major drugs for glaucoma treatment are Lumigan, Combigan, Xalatan, Ganfort and Saflutan. Diquas, Hyalein and Restasis are the major drugs for dry eye diseases. The retinal drugs market includes Ozurdex, Macugen, Visudyne and Lucentis. Patanol/Pataday, Tobradex, Vigamox and Bepreve are major ocular anti-inflammatory drugs. The ophthalmic drugs market covers prescription based drugs, OTC drugs and pipeline drugs. This report forecasts future potential of all these drug markets and analyses drivers and opportunities, restraints and challenges, market trends, Porter's forces, competitive landscape and company profiles of key players.
The report categorizes the global ophthalmic drugs market based on major eye disorders, treatment drugs and geography. The treatment drugs market comprises treatment of major eye disorders such as glaucoma, dry eye drugs, retinal diseases and ocular inflammatory diseases. The market is further segmented on the basis of prescription based drugs, OTC drugs and pipeline drugs in different eye disorder areas.
In the segment of geographic analysis, the report identifies and analyses market sizes and forecast of North America, Europe, Asia Pacific and Rest of the World (RoW). North America region covers the scenario of the US. Europe region covers the scenario of France, Germany and the UK. Asia Pacific region highlights the scenario of India, China and Japan.
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Ophthalmic Drugs - Industry Analysis
Chapter 4 Ophthalmic Drugs Market Trends
Chapter 5 Porter's Five Force Analysis
Chapter 6 Global Market Size and Forecast
Chapter 7 Ophthalmic Drugs Market - Treatment Drugs
Chapter 8 Ophthalmic Drugs Market: Regional Analysis
Chapter 9 Prescription vs. Over the Counter Drugs
Chapter 10 Competitive Landscape
Chapter 11 Company Profiles
- Santen Pharmaceutical
For more information visit http://www.researchandmarkets.com/research/9kp9sq/ophthalmic_drugs
Media Contact: Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets